These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection. Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174 [TBL] [Abstract][Full Text] [Related]
28. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis. Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056 [TBL] [Abstract][Full Text] [Related]
29. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055 [TBL] [Abstract][Full Text] [Related]
30. Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience. Choi CI; Kang M; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SIL Clin Genitourin Cancer; 2018 Dec; 16(6):e1189-e1199. PubMed ID: 30262447 [TBL] [Abstract][Full Text] [Related]
31. Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Donskov F; Xie W; Overby A; Wells JC; Fraccon AP; Sacco CS; Porta C; Stukalin I; Lee JL; Koutsoukos K; Yuasa T; Davis ID; Pezaro C; Kanesvaran R; Bjarnason GA; Sim HW; Rathi N; Kollmannsberger CK; Canil CM; Choueiri TK; Heng DYC Eur Urol Oncol; 2020 Aug; 3(4):530-539. PubMed ID: 32037304 [TBL] [Abstract][Full Text] [Related]
32. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013. Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248 [TBL] [Abstract][Full Text] [Related]
34. Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort. Russell CM; Espiritu PN; Kassouf W; Schwaab T; Buethe DD; Dhilon J; Sexton WJ; Poch M; Powsang JM; Tanguay S; Nayan M; Alsaadi H; Hanzly MI; Spiess PE J Urol; 2014 Aug; 192(2):350-6. PubMed ID: 24530987 [TBL] [Abstract][Full Text] [Related]
35. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma. Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753 [TBL] [Abstract][Full Text] [Related]
36. Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis. Feuerstein MA; Kent M; Bernstein M; Russo P Int J Urol; 2014 Sep; 21(9):874-9. PubMed ID: 24712686 [TBL] [Abstract][Full Text] [Related]
37. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration. Chipollini J; Abel EJ; Peyton CC; Boulware DC; Karam JA; Margulis V; Master VA; Zargar-Shoshtari K; Matin SF; Sexton WJ; Raman JD; Wood CG; Spiess PE Clin Genitourin Cancer; 2018 Apr; 16(2):e443-e450. PubMed ID: 29113770 [TBL] [Abstract][Full Text] [Related]
38. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies? Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934 [TBL] [Abstract][Full Text] [Related]
39. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases. Dell'Oglio P; Larcher A; Muttin F; Di Trapani E; Trevisani F; Ripa F; Carenzi C; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U Urol Oncol; 2017 Nov; 35(11):662.e9-662.e15. PubMed ID: 28801027 [TBL] [Abstract][Full Text] [Related]
40. Can Retroperitoneal Lymph Node Dissection (RPLND) be feasibly performed to prolong survival in Renal Cell Carcinoma (RCC) with limited lymph node involvement? An Analysis of Recurrence Patterns. Tachibana I; Vasquez R; Mahmoud M; Kern SQ; Patel RS; King J; Adra N; Boris RS; Cary C; Rice KR Urol Oncol; 2022 Nov; 40(11):495.e11-495.e17. PubMed ID: 36154800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]